How to read these charts
Against the national standards
Each measure is drawn against its own NHS England standard: 95% for A&E within four hours, 85% for urgent cancer treatment within sixty-two days and 99% for diagnostic tests within six weeks. The charts do not share a standard and the three cancer measures are never added together.
Care Quality Commission
When CQC last rated this body
CQC has not rated Royal Berkshire NHS Foundation Trust since 7 January 2020. Its judgements from then are still on CQC’s own site and are not shown here, because a rating more than 3 years old is not what CQC currently says about a body.
Monthly performance against national standards
Hover or use the arrow keys to read any month, with the figures the percentage was worked out from. Every chart opens as a table.
A&E Wait Times
Patients seen within four hours
75.4%
August 2026: 75.4 per cent, 13,655 of 18,118 attendances. Below the 95% standard.
All 17 months as a table
| Month | Performance | Of attendances |
|---|---|---|
| Aug 2026 | 75.4%, Below the 95% standard | 13,655 of 18,118 |
| Jul 2026 | 77.9%, Below the 95% standard | 14,970 of 19,208 |
| Jun 2026 | 76.1%, Below the 95% standard | 14,429 of 18,963 |
| May 2026 | 75.4%, Below the 95% standard | 14,591 of 19,346 |
| Apr 2026 | 76.5%, Below the 95% standard | 13,957 of 18,247 |
| Mar 2026 | 76.9%, Below the 95% standard | 14,319 of 18,612 |
| Feb 2026 | 75.4%, Below the 95% standard | 12,106 of 16,055 |
| Jan 2026 | 73.2%, Below the 95% standard | 12,903 of 17,640 |
| Dec 2025 | 76.4%, Below the 95% standard | 13,221 of 17,314 |
| Nov 2025 | 77.8%, Below the 95% standard | 13,553 of 17,419 |
| Oct 2025 | 74.6%, Below the 95% standard | 13,678 of 18,334 |
| Sept 2025 | 74.9%, Below the 95% standard | 13,082 of 17,467 |
| Aug 2025 | 76.4%, Below the 95% standard | 12,680 of 16,588 |
| Jul 2025 | 78.1%, Below the 95% standard | 14,078 of 18,029 |
| Jun 2025 | 75.2%, Below the 95% standard | 13,179 of 17,532 |
| May 2025 | 71.2%, Below the 95% standard | 12,323 of 17,318 |
| Apr 2025 | 71.3%, Below the 95% standard | 11,463 of 16,083 |
Waiting times (RTT)
Referral to treatment: waiting under eighteen weeks to start treatment
83.3%
July 2026: 83.3 per cent, 29,054 of 34,892 people waiting. Below the 92% standard.
All 14 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 83.3%, Below the 92% standard | 29,054 of 34,892 |
| Jun 2026 | 84.4%, Below the 92% standard | 29,664 of 35,155 |
| May 2026 | 83.1%, Below the 92% standard | 30,008 of 36,116 |
| Apr 2026 | 83.4%, Below the 92% standard | 29,460 of 35,323 |
| Mar 2026 | 83.8%, Below the 92% standard | 29,053 of 34,676 |
| Feb 2026 | 82.2%, Below the 92% standard | 28,583 of 34,767 |
| Jan 2026 | 83.5%, Below the 92% standard | 28,841 of 34,560 |
| Dec 2025 | 82.2%, Below the 92% standard | 28,125 of 34,236 |
| Nov 2025 | 81.7%, Below the 92% standard | 27,917 of 34,174 |
| Oct 2025 | 81.4%, Below the 92% standard | 28,933 of 35,561 |
| Sept 2025 | 80.9%, Below the 92% standard | 27,929 of 34,512 |
| Aug 2025 | 79.7%, Below the 92% standard | 27,891 of 35,016 |
| Jul 2025 | 79.9%, Below the 92% standard | 29,376 of 36,763 |
| Jun 2025 | 79.9%, Below the 92% standard | 29,190 of 36,524 |
Diagnostic tests (DM01)
Waiting under six weeks for a scan, a scope or a test
91.0%
July 2026: 91.0 per cent, 9,066 of 9,965 people waiting. Below the 99% standard.
All 4 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 91.0%, Below the 99% standard | 9,066 of 9,965 |
| Jun 2026 | 82.9%, Below the 99% standard | 8,551 of 10,310 |
| May 2026 | 81.7%, Below the 99% standard | 8,101 of 9,918 |
| Apr 2026 | 77.1%, Below the 99% standard | 8,339 of 10,813 |
Cancer diagnosis (FDS)
Faster diagnosis standard: told the outcome within twenty-eight days
84.4%
July 2026: 84.4 per cent, 2,192 of 2,597 referrals. Meets the 75% standard.
All 7 months as a table
| Month | Performance | Of referrals |
|---|---|---|
| Jul 2026 | 84.4%, Meets the 75% standard | 2,192 of 2,597 |
| Jun 2026 | 84.7%, Meets the 75% standard | 2,113 of 2,496 |
| May 2026 | 86.0%, Meets the 75% standard | 1,959 of 2,277 |
| Apr 2026 | 84.0%, Meets the 75% standard | 1,823 of 2,170 |
| Mar 2026 | 87.1%, Meets the 75% standard | 2,125 of 2,439 |
| Feb 2026 | 85.6%, Meets the 75% standard | 2,022 of 2,361 |
| Jan 2026 | 80.0%, Meets the 75% standard | 1,894 of 2,368 |
Cancer (31-day)
Decision to treat to first treatment within thirty-one days
93.0%
July 2026: 93.0 per cent, 561 of 603 treatments. Below the 96% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 93.0%, Below the 96% standard | 561 of 603 |
| Jun 2026 | 94.8%, Below the 96% standard | 552 of 582 |
| May 2026 | 92.9%, Below the 96% standard | 432 of 465 |
| Apr 2026 | 89.1%, Below the 96% standard | 459 of 515 |
| Mar 2026 | 90.9%, Below the 96% standard | 449 of 494 |
| Feb 2026 | 89.5%, Below the 96% standard | 469 of 524 |
| Jan 2026 | 89.3%, Below the 96% standard | 482 of 540 |
Cancer (62-day)
Urgent referral to first treatment within sixty-two days
81.4%
July 2026: 81.4 per cent, 206 of 253 treatments. Below the 85% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 81.4%, Below the 85% standard | 206 of 253 |
| Jun 2026 | 79.4%, Below the 85% standard | 185 of 233 |
| May 2026 | 77.2%, Below the 85% standard | 165.5 of 214.5 |
| Apr 2026 | 78.7%, Below the 85% standard | 171.5 of 218 |
| Mar 2026 | 78.9%, Below the 85% standard | 181 of 229.5 |
| Feb 2026 | 77.8%, Below the 85% standard | 170 of 218.5 |
| Jan 2026 | 75.7%, Below the 85% standard | 174 of 230 |